Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4510_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
32 Мб
Скачать
200
P.J. de CavalcantiSiebra et al.
inferiorly through the innominate artery. The colon–pharyngocutaneous stula was again primarily closed. The left PM ap was used for mediastinal vessel cov­erage and a right deltopectoral ap was used to reinforce the neck coverage (Figs.17 and 18).
The patient was evaluated with a colon–pharyngocutaneous stula that needed to be closed twice during hospitalization with resuturing of the edges, but with no complications of MT.The patient was discharged for ambulatory control in the third postoperative month after the rst surgery (Fig.19).
Currently, 10months after the rescue surgery and 7months after MT, there is no evident disease and no surgical complications. The patient presented with just a single episode of moderated pneumonia, which needed a short hospitalization for systemic antibiotic therapy.
Fig. 17 Colon–pharyngeal anastomosis of the neck with good extension
Mediastinal Tracheostomy
Fig. 18 Resection of the manubrium and clavicular heads
Fig. 19 Deltopectoral ap
201
Discussion andOutcomes
In our reported case, the rst treatment planned was a radical surgical resection because there was locally advanced cancer. However, the patient refused this treat­ment plan, leading to completion of a chemotherapy regimen of induction (TPF)
202
P.J. de CavalcantiSiebra et al.
associated with concurrent radiotherapy with cetuximab. This treatment consisted of three cycles 21days apart (75mg/m2 Taxol on day1, 35mg/m2 platinum on days 1 and2, and 750mg/m2 5-uorouracil on days1–5) as an adjunct to radiotherapy with the intention to preserve organs with control comparable to that of surgical treatment. An advantage of this treatment is a better laryngeal preservation rate than that achieved with exclusive use of radiotherapy. In addition, replacement of cispla­tin by cetuximab has lower levels of toxicity when performed concurrently with radiation therapy. A laryngopharyngoesophagectomy would be the gold standard treatment in this case, but the patient declined it.
MT consists of a procedure that is usually indicated for re-establishment of an alternative airway after resection of advanced tumors, especially after laryngophar­yngectomy associated with esophagectomy, and after resection of recurrence in the tracheostoma [4]. In the presented case, the indication was not because of a tumor, but as a way of solving a surgical complication of the rst procedure: anastomotic dehiscence with migration of the remaining trachea into the mediastinum.
The current literature shows small series of cases, often obtained over decades. However, these studies show the degrees of morbidity and mortality associated with this procedure as well as the techniques used to protect the artery and innominate vein.
Orringer studied 44 patients who underwent MT, ten as a palliative procedure and another 34 (72%) for airway reconstruction after cervical exenteration (pharyngolar­yngectomy with esophagectomy). Of the latter, 31 had alimentary tract reconstruction by gastric transposition and three by transposition of the colon. A perioperative mor­tality rate of 14% (six deaths) was observed, all in patients who underwent cervical exenteration. Only nine patients (32%) had a postoperative course without complica­tions. The length of stay ranged from 10 to 51days (median 26.2days). Only one patient had a rupture of the innominate artery, in which the trachea was not transposed down the artery. Orringer reported that the critical factor to avoid fatal complications was elimination of tension between the structures, which could be achieved with implementation of the trachea below the innominate artery.
In the work of Kamiyama etal. [20], 40 patients undergoing pharyngolaryngec­tomy with total esophagectomy were studied. MT was performed in nine cases (22.5%), and of these, four (44%) had complications related to the tracheostomy. Of the 31 patients who underwent traditional tracheostomy, only four (12.5%) had complications related to ostomy. Survival at 5years was 48.6% and perioperative mortality was 5% (two deaths: one by bleeding due to brachiocephalic vein injury and the other due to injury of the innominate artery).
Berthet [9] evaluated 12 patients undergoing MT, all for recurrence in stoma after laryngectomy. In all 12 surgeries, relocation of tracheal segments remaining below the innominate artery and a myocutaneous ap to cover the tracheostomy were necessary. Reconstruction of the alimentary tract was required in four patients (three with gastric transposition and one with primary closure). There was one death in the postoperative period (8.3%), due to a vascular stula. The length of hospital stay varied between 13 and 86days. Survival at 5years was 53%. The author con­cluded that despite the surgical risks, long-term survival after total resection of the lesion is acceptable.
Mediastinal Tracheostomy
203
Grillo [19] and Mathisen described modications in the MT and cervical exen­teration techniques. They performed a prophylactic ligation of the innominate artery in all patients with some degree of tension between the tracheal stump and the mediastinal vessels under electroencephalographic monitoring. Prior to sur­gery, all patients underwent arteriography to assess the cerebral vasculature and the patency of the Willis polygon. The authors also used the omentum to cover the artery stumps and to separate them from the trachea, and gave preference to a bipedicled ap for cutaneous coverage of the tracheostoma. They performed MT in 14 cases in a series of 18 patients who underwent cervical exenteration. The innominate artery had to be divided in seven of these patients. Of these seven, only one had hemiplegia, which was treated through a bypass to the left subcla­vian artery. Alimentary tract reconstruction was performed, preferably by choice of the colon, transposing it through a substernal tunnel. In this study, the colon was used for reconstruction in ten patients, while the stomach was used only in three. There was one death in the study due to anastomotic leakage in a recon­struction with a gastric tube, which resulted in mediastinal sepsis. The median survival was 10months, and six patients survived for more than 4years. The authors describe functional results equivalent to laryngectomy and recommend this procedure for palliation only in cases with a survival prediction longer than 6months.
Chan etal. [18] studied 38 patients with cervical–mediastinal tumors who under­went MT.There was no artery ligation in any case. Of these 38, 31 (81.6%) required repositioning of the trachea below the innominate artery to prevent tension and 14 patients required a PM ap for tracheostoma closure. Digestive tract reconstruction was necessary in 34 cases, of which eight had a primary closing of the neopharynx. A jejunum free ap was used in eight cases, the gastric tube was transposed in 12, and a tubed PM ap was made in six patients. The authors described in-hospital mortality of 5.3% (two deaths) due to bleeding of the great vessels. There was a leakage from the gastrointestinal anastomosis in six patients (three who underwent gastric transposition and three who had reconstruction with a tube-shaped PM). Eleven patients (28.9%) had ischemia or partial necrosis of the terminal portion of the trachea. During follow-up, 18 patients (47.4%) had stenosis of the tracheos­toma. In these cases, a history of leakage from the anastomosis or tracheal ischemia was statistically signicant as a risk factor for tracheostoma stenosis (p=0.34 and p=0.26, respectively). The PM ap was considered a protective factor, inasmuch as tracheostoma stenosis occurred in just one patient (7.1% of those who underwent it). The survival rates were 80.6% at 1year and 55.6% at 5years. The authors rec­ommended not skeletonizing the terminal stump of the trachea to prevent its ischemia.
In a study involving 13 patients undergoing MT, Conti etal. described two in­hospital deaths (one for bleeding of the innominate artery) and only ve cases with no complications. The average hospital stay was 29 days, ranging from 12 to 101days. The survival rates at 3 and 5years were 57% and 43%, respectively. Worse outcomes were observed in patients operated on for esophageal carcinoma or for laryngeal carcinoma recurrence.
204
P.J. de CavalcantiSiebra et al.
In the existing literature, when a complete resection of the esophagus occurs, the main options are the gastric pull-up, colonic transposition, and transposition of the jejunum, with the choice depending on the service experience and the specic con­ditions of the patient (previous gastrostomy, prior laparotomy, and previous colonic or jejunal surgery). When the gastric pull-up is chosen, there is the possibility of distal ischemia or gastric stump ischemia, which rarely happens with the colon. Furthermore, the colon can provide a large segment for reconstruction, but at the expense of increased intra-abdominal anastomoses. In cases where only the cervical esophagus is resected, the microsurgical jejunal ap is a good option, as are tubed myocutaneous aps (e.g., the anterolateral thigh ap and forearm ap) [5, 6, 11].
MT is an important option for airway reconstruction where there is an insuf­cient length of trachea to perform the traditional procedure in the cervical region. There was a decrease in the incidence of innominate artery rupture after the use of aps for coverage and fashioning of a tension-free trachea–skin anastomosis [4]. Although it has a high rate of complications, MT continues to be viable in well­selected patients, as observed in our case report.
To conclude, MT is an exceptional procedure due to the morbidity and risks it presents and should be performed only in patients with an excellent general condi­tion. It may also be indicated as a palliative treatment in selected cases. This report shows the feasibility of its use associated with laryngopharyngoesophagectomy for a locally advanced tumor. The surgeon should be aware of the possibility of esopha­gectomy, with several options for gastrointestinal transit reconstruction.

References

1. Gomez-Caro A, Gimferrer JM, Macchiarini P.Technique to avoid innominate artery ligation
and perform an anterior mediastinal tracheostomy for residual trachea of less than 5cm. Ann Thorac Surg. 2007;84:1777–9.
2. Grillo HC, Mathisen DJ.Cervical exenteration. Ann Thorac Surg. 1990;49:401–9.
3. Orringer MB.Anterior mediastinal tracheostomy with and without cervical exenteration. Ann
Thorac Surg. 1992;54:628–37.
4. Conti M, Benhamed L, Mortuaire G, Chevalier D, Pinçon C, Wurtz A.Indications and results
of anterior mediastinal tracheostomy for malignancies. Ann Thorac Surg. 2010;89(5):1588–95.
5. Carlson GW, Schusterman MA, Guillamondegui OM.Total reconstruction of the hypopharynx
and cervical esophagus: a 20 year experience. Ann Plast Surg. 1992;29:408–12.
6. de Vries EJ, Stein DW, Johnson JT, etal. Hypopharyngeal reconstruction: a comparison of two
alternatives. Laryngoscope. 1989;99:614–7.
7. Maipang T, Singha S, Panjapiyakul C, Totemchokchyakam P.Mediastinal tracheostomy. Am J
Surg. 1996;171:581–6.
8. Jatin Shah 2012 Head and Neck Surgery and Oncology, 4th Edition. ISBN978–0–323-05589-5.
9. Berthet JP, Garrel R, Gimferrer JM, Paradela M, Marty-Ané CH, Molins L, Gómez-
Caro A. Anterior mediastinal tracheostomy as salvage operation. Ann Thorac Surg. 2014;98(3):1026–33.
10. Goldberg M, Freeman J, Gullane PJ, etal. Transhiatal esophagectomy with gastric transposi-
tion for pharyngolaryngeal malignant disease. J Thorac Cardiovasc Surg. 1989;97:327–33.
11. Goligher JC, Robin IG.Colon in reconstruction after pharyngectomy: use of left colon for
reconstruction of pharynx and esophagus after pharyngectomy. Br J Surg. 1954;42:283–90.
12. Gomez-Caro A, Gimferrer JM, Molins L.Lung Incarceration after anterior mediastinal trache-
ostomy. Ann Thorac Surg. 2013;95:1795–7.
Mediastinal Tracheostomy
13. Patel UA, Moore BA, Wax M, etal. Impact of pharyngeal closure techniqueon stula after
salvage laryngectomy. JAMA Otolaryngol Head Neck Surg. 2013;139:1–6.
14. Paydarfar JÁ, Birkmeyer NJ. Complications in head and neck surgery: a meta-analysis of
postlaryngectomy pharyngocutaneous stula. Arch Otolaryngol Head and Neck Surg. 2003;132:67–72.
15. Sisson GA, Strachley CJ Jr, Johnson NE.Mediastinal dissection for recurrent cancer after
laryngectomy. Laryngoscope. 1962;72:1064–77.
16. Terz JJ, Wagman LD, King RE, etal. Results of extended resection of tumours involving the
cervical part of the trachea. Surg Gynecol Obstet. 1980;151:491–6.
17. Waddell WR, Cannon B.A technic for subtotal excision of the trachea and establishment of a
sternal tracheostomy. Ann Surg. 1959;149:1–8.
18. Chan YW, Yu Chow VL, Lun Liu LH, Ignace Wei W.Manubrial resection and anterior medi-
astinal tracheostomy: friend or foe? Laryngoscope. 2011;121:1441–5. https://doi.org/10.1002/
lary.21.
19. Grillo HC.Terminal or mural tracheostomy in the anterior mediastinum. J Thorac Cardiovasc
Surg. 1966;51:422–7.
20. Kamiyama R, Mitani H, Yonekawa H, Fukushima H, Sasaki T, Shimbashi W, Seto A, Koizumi
Y, Ebina A, Kawabata K. A clinical study of pharyngolaryngectomy with total esophagec­tomy: postoperative complications, countermeasures, and prognoses. Otolaryngology Head and Neck Surgery. 2015;153:392–9. rst published on June 26, 2015.
21. Kleitsch WP.Anterior mediastinal tracheostomy. J Thorac Surg. 1952;24:38–42.
22. Minor GR.Trans-sternal tracheal excision for carcinoma. J Thorac Surg. 1952;24:88–92.
23. Watson WL.Cancer of the trachea fourteen years after treatment for cancer of larynx. J Thorac
Surg. 1942;12:142–50.
24. Sugarbaker DJ, Bueno R, Colson YL, Jaklitch MT, Krasna MJ, Mentzer SJ, Williams M,
Adams A.Adult chest surgery. 2nd ed. NewYork: McGraw-Hill Education; 2015. https://
accesssurgery.mhmedical.com/book.aspx?bookID=1317.
205

Transtumoral Tracheostomy

DorioJoseCoelhoSilva, RicardoMaiRocha, TerencePiresde Farias, andRafaelViannaLocio

Introduction

Tracheostomy is a surgical procedure indicated for maintenance of the airway in patients with severe respiratory insufciency due either to mechanical obstruction of the upper airways or obstruction resulting from retention of secretions, insuf­cient ventilation, or both [1]. In this chapter we will mainly pay attention to mechan­ical obstructions, which are usually due to changes in the anatomy of the larynx, trachea, oropharynx, and hypopharynx, and, in specic cases (and more usually in the specialty of head and neck surgery), are caused by advanced malignant neopla­sia. There are several tumors of the upper digestive tract or cervical masses that can compress and deect the airway (Fig.1); among these, we highlight those most frequent in our practice: malignant neoplasms of the larynx, anaplastic carcinoma, thyroid lymphoma, and bulky submarining goiters with airway compression [1, 2].
D.J.C. Silva, M.D. Department of Head and Neck Surgery, Evangelic Hospital of Vila Velha, Vila Velha, Brazil
R.M. Rocha, M.D. ( Assistant Professor of Head and Neck Surgery, Universidade Federal do Espirito Santo, Vitoria, Brazil
Assistant Professor of Head and Neck Surgery, Faculdade Brasileira Multivix, Vitoria, Brazil e-mail: ricardomai@gmail.com
T.P. de Farias, M.D., Ph.D., M.Sc., Researcher. Department of Head and Neck Surgery, Brazilian National Cancer Institute—INCA, Rio de Janeiro, RJ, Brazil
Department of Head and Neck Surgery, Pontical Catholic University, Rio de Janeiro, RJ, Brazil
R. Vianna Locio, M.S., (Medical Student). Faculdade Pernambucana de Saúde/IMIP — Maternity Childhood Institute of Pernambuco, Recife, PE, Brazil
© Springer International Publishing AG 2018 T.P. de Farias (ed.), Tracheostomy, https://doi.org/10.1007/978-3-319-67867-2_12
*)
207
208
ab
Fig. 1 Large lesion affecting the cervical topography with important tracheal deviation to the right
D.J.C. Silva et al.
Anaplastic thyroid carcinoma is a rare neoplasm and highly aggressive, with survival often measured in months. It may be associated with a well-differentiated thyroid neoplasm and long-term goiter. The nding of an association between ana­plastic carcinoma and a well-differentiated thyroid tumor is usually made during investigation of the anaplastic carcinoma within a piece of a well-differentiated car­cinoma on histological analysis [3, 4].
It is believed that the incidence of anaplastic carcinoma has decreased due to the appearance and improvement of immunohistochemical studies facilitating more accurate diagnosis, iodine supplementation in the diet, and more aggressive treat­ment of well-differentiated thyroid carcinomas [3, 4].
It is estimated that anaplastic thyroid carcinoma is associated with 1–3% of benign and malignant tumors of the thyroid, although some studies have observed an increase in this ratio primarily related to geographic factors (iodine intake de­ciency and endemic goiter) [4].
The age of greatest incidence varies from 50 to 90years, and it is very rare in patients below 50years of age (<10%). There is a predominance of females, in a proportion of 3:1 [4].
Many studies have suggested an origin of undifferentiated thyroid carcinoma in thyroid with some diseases such as goiter (80%), adenoma, or even a well­differentiated carcinoma. A strong association between prior history and the histol­ogy of this tumor has led many researchers to suspect a malignant transformation from a benign condition or a well-differentiated carcinoma into a highly malignant neoplasm. Approximately 20% of patients with anaplastic thyroid carcinoma pre­sented with a previous history of a well-differentiated thyroid carcinoma, and 20–30% had a coexisting differentiated carcinoma. The commonly associated dif­ferentiated carcinoma is papillary, but a follicular tumor may also have this associa­tion. Approximately 10% of patients with Hürthle cell carcinoma have foci of anaplastic carcinoma in surgical specimens [5].
Transtumoral Tracheostomy
209
As we have seen, anaplastic carcinoma arises from one or another point of dedif­ferentiation, particularly mutation of the p53 tumor suppressor protein. No precipi­tating effect has been identied, and the mechanisms that lead to emergence of an undifferentiated tumor from a well-differentiated carcinoma remain uncertain [5].
Almost all patients present with an often palpable and voluminous thyroid mass. However, regional or remote dissemination may be present in up to 90% of cases. The most frequent sites of regional involvement are the perithyroid tissues (fat and muscles), lymph nodes, larynx, trachea, esophagus, pharynx, and large cervical and mediastinal vessels. The lungs are the main sites of distant metastasis (up to 90%), followed by the bones and brain, at a much lower frequency [4, 6].
Usually the rst symptom is rapid growth of a cervical mass, occurring in up to 85% of patients. This growth can cause cervical pain and compression (or invasion) of the upper aerodigestive tract, resulting in dyspnea, dysphagia, dysphonia, cough, and sometimes hemoptysis. Up to 50% of patients may have enlarged cervical lymph nodes, and other ndings include laryngeal stridor, tracheal deviation, or even signs of compression of the superior vena cava [6].
Imaging diagnosis is important in assessing the extent of disease, in therapeutic planning, and in monitoring of the response to treatment. Thoracic radiography is important in evaluating the presence of pulmonary metastases, as well as evaluation of bone metastases in ribs or spine. Ultrasonography of the neck is important in determining local involvement and regional lymph nodes, as well as suggesting, if there is extrathyroidal extension, that the thyroid tumor is a malignant neoplasm. Computed tomography (CT) of the neck and mediastinum should delineate the extent of the thyroid tumor and identify invasion of large vessels and the upper aerodigestive tract [4].
Several characteristics are important in the prognosis of patients. Patients who have disease conned to the thyroid, or who have disease with local or regional extension, have longer survival than those with distant metastases. Tumor size also seems to be important [7].
Other characteristics that present an adverse prognosis are advanced age at diag­nosis, male gender, and presence of dyspnea as the initial symptom [8].
Many patients with anaplastic carcinoma die within a few months, primarily due to local extension and airway obstruction, with a median survival of only 3–4months [7, 8].
Surgery is rarely indicated in these patients, certainly given the advanced-stage diagnosis in the vast majority of cases; however, if the tumor appears to be conned to the thyroid, surgery should be attempted not only to improve the prognosis but also to facilitate adjuvant treatment [9].
In the most severe cases where neoplastic involvement of the cervical area is already present, we perform a transtumoral tracheostomy. A neoplastic lesion involving a course of surgery can completely distort the anatomy, compromising important structures, and necessitating a more accurate surgical technique requiring care beyond the tracheal site itself [9, 10].
When tracheal deviation is suspected, it is prudent to carry out a follow-up exam­ination to identify where the new airway is located, which is normally unnecessary
210
ab
Fig. 2 (a) Tracheal deviation visible during surgery. (b) Drawing of the tracheal deviation prior to surgery
D.J.C. Silva et al.
Fig. 3 An X-ray may be useful in identifying the new site of the trachea after deviation by the neoplastic process
during standard tracheostomy (Fig.2). Depending on the time and the setting for performing the tracheostomy, even a cervical X-ray (Fig.3) helps in dening the most appropriate access site to avoid wasting surgical time. More accurate examina­tions such as CT or magnetic resonance imaging (MRI) are obviously more infor­mative, and their indication depends basically on the availability and speed with which they can be performed [11].
At times, there is no way to avoid access via the cricoid or even higher (Fig.4), via the thyroid cartilage, which, depending on the neoplastic situation, is already literally destroyed by the lesion [1, 2, 12].